UNSPSC 51352308: Pipendoxifene

This classification denotes a selective estrogen receptor modulator with the molecular formula C29H32N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TPC5Q8496G. The term PIPENDOXIFENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 no. 3-4, 2001, list 46. ). Most nations schedule pipendoxifene under HS 29333999 and SITC 51574. As of Q4 2014, PIPENDOXIFENE remains the US FDA Preferred Term for this commodity.

Pipendoxifene bears US NLM identifiers UMLS ID C0935699 and NCI Concept Code C1874. SMILES: CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCC4)C5=CC=C(C=C5)O.

UNSPSC 51352308 Pipendoxifene is a Commodity code representing pharmaceutical active ingredients and finished-form medicines that state and local governments procure through cooperative purchasing agreements and direct supply contracts. Recent solicitations under this code show state and local entities purchasing generic multi-source pharmaceuticals and over-the-counter products for distribution across government facilities, with vendors required to demonstrate cGMP certification, FDA compliance, Drug Supply Chain Security Act adherence, and relationships with authorized pharmaceutical wholesalers. The work involves supplying identified pharmaceutical products with specific National Drug Codes, packaging configurations, and pricing structures negotiated through formal RFP processes, with contract awards weighted heavily on price competitiveness (75 percent) alongside administrative compliance and EDI capability.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, has issued a Request for Proposal (S1070000015802) posted January 20, 2026, with a response due date of March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and over-the-counter products for participating state and local government facilities across Minnesota and Oregon. Awarded vendors will supply products through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and must maintain commercial general liability insurance of $5,000,000 per occurrence, network security and privacy liability of $2,000,000, and professional liability of $2,000,000. Contract terms run two years for new responders with optional extensions at MMCAP's sole discretion, effective July 1, 2026, with vendors subject to a 3 percent administrative fee and performance penalties ranging from $200 to $1,500 per violation for late reporting, missed onboarding timelines, or improper class-of-trade denials.